Impact of Continuous Positive Airway Pressure on the Treatment of Acute Asthma Exacerbation
This current study aimed to demonstrate the effectiveness of the addition of CPAP to the current conventional therapy in terms of airway obstruction improvement in acute asthma patients.
|Study Design:||Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
|Official Title:||Impact of Continuous Positive Airway Pressure on the Treatment of Acute Asthma Exacerbation|
- an improvement in PEFR, as % predicted [ Time Frame: 75 mins ] [ Designated as safety issue: No ]
|Study Start Date:||April 2009|
|Study Completion Date:||January 2011|
|Primary Completion Date:||January 2010 (Final data collection date for primary outcome measure)|
Device: Continuous positive airway pressure
CPAP 8 cmH2O
Other Name: GoodKnight 420 G; Nellcor Puritan Bennett Inc.
Continuous positive airway pressure (CPAP) is widely used in providing ventilator support. However, its role in an acute asthmatic attack is uncertain. The purpose of this study was to compare the efficacy of CPAP when used in addition to conventional therapy with conventional therapy alone in the management of acute asthma exacerbation.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01403467
|Bangkok, Thailand, 10400|
|Principal Investigator:||Yuda Sutherasan, M.D.||Ramathibodi Hospital, Mahidol University|